机译:舒尼替尼有效治疗转移性Xp11.2易位肾细胞癌的案例研究
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan;
Department of Urology, Akita University Graduate School;
Renal cell carcinoma; Xp11.2 translocation; Sunitinib; Fluorescence in situ hybridization;
机译:舒尼替尼有效治疗转移性Xp11.2易位性肾细胞癌的案例研究。
机译:吉西他滨联合舒尼替尼治疗转移性肾细胞癌1例
机译:Xp11.2易位肾细胞癌患者中,舒尼替尼诱导的肾病综合征与药物反应相关。
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
机译:吉西他滨联合舒尼替尼治疗转移性肾细胞癌1例
机译:吉西他滨和孙尼替尼有效治疗转移性肾细胞癌的情况